ABIGAIL GERKEN: Open Payments
NPI 1538697230 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 79 payments from 17 companies in 2025. Trend: 2023 $1,246 · 2024 $1,273 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 13 | $380 |
| ABBVIE INC. | 28 | $296 |
| Novo Nordisk Inc | 13 | $140 |
| Otsuka America Pharmaceutical, Inc. | 4 | $68 |
| Exact Sciences Corporation | 2 | $48 |
| Corium, LLC | 6 | $42 |
| Impel Pharmaceuticals LLC | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| PFIZER INC. | 1 | $19 |
Products named: EVENITY, VRAYLAR, REPATHA, Rybelsus, QULIPTA, REXULTI, Ozempic, Azstarys.
Industry payments across AZ — which companies pay providers there.
